Login
$HEPA
$0.09 +$0.02 (33.33%) Close

$HEPA SEC Filings

Filed On Filing
26 Oct 2026 SCHEDULE 13D
21 Oct 2026 Form 3: Gravitas Collective Corp., Director

Holds 25,000,000 shares of Common Stock

21 Oct 2026 SCHEDULE 13G/A
14 Oct 2026 S-8
09 Oct 2026 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +2 more

This Membership Interest Purchase Agreement (this “Agreement”), dated as of October 6, 2026, by and among Hepion Pharmaceuticals, Inc., a Delaware corporation (the “Buyer”), Gravitas Life Sciences, LLC, a Delaware limited liability compa...

02 Oct 2026 Form 4: Fisher Danina, Director

Bought 200,000 shares ($10K) · Acquired 200,000 Warrants (Open Market Purchase)

02 Oct 2026 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

HEPION PHARMACEUTICALS, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows:

28 Sep 2026 8-K: Changes in Registrant's Certifying Accountant

We have read the statements made by Hepion Pharmaceuticals, Inc. under Item 4.01 of its Form 8-K dated September 24, 2026, and we agree with the statements concerning our Firm in such Form 8-K. We have no basis to agree or disagree with ...

16 Sep 2026 Form 3: Ki Holdings, Ltd., 10% owner

Holds 10,000,000 shares of Common Stock

16 Sep 2026 SCHEDULE 13D/A
15 Sep 2026 SCHEDULE 13G
14 Sep 2026 Form 4: LoPriore Vincent S, Director

Acquired 12,500,000 Warrants (Open Market Purchase)

10 Sep 2026 DEF 14C
10 Sep 2026 Form 4: Purcell Michael J., Director

Granted 299,000 Stock Options

08 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

THIS CONVERTIBLE NOTE PURCHASE AGREEMENT (the “Agreement”) is made as of September 3, 2026, by and between Hepion Pharmaceuticals, Inc., a Delaware corporation (and together with all of its current and future, direct and/or indirect, who...

31 Aug 2026 PRE 14C
27 Aug 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
21 Aug 2026 Form 4: Stetz Gary S., Director

Granted 1,345,500 Stock Options

21 Aug 2026 Form 4: LoPriore Vincent S, Director

Granted 1,345,500 Stock Options

21 Aug 2026 Form 4: LoPriore Chase, Director

Granted 1,345,500 Stock Options

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support